These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34668119)

  • 1. Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps.
    Liao CT; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Chien CY; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chen WC; Lee LY; Lin CY; Wang HM; Fang TJ; Huang SF; Kang CJ; Chang KP; Yen TC; Yang LY; Lin CH;
    Ann Surg Oncol; 2022 Feb; 29(2):1130-1140. PubMed ID: 34668119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction.
    Hafström A; Wahlberg P; Klasson S; Greiff L; Sjövall J
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2953-2964. PubMed ID: 36897366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should sub-millimeter margins be deemed positive in oral cavity squamous cell carcinoma?
    Kang CJ; Lee LY; Ng SH; Lin CY; Fan KH; Chen WC; Lin JC; Tsai YT; Lee SR; Chien CY; Hua CH; Ping Wang C; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Wen YW; Liao CT
    Oral Oncol; 2024 Apr; 151():106745. PubMed ID: 38460286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
    Sunkara PR; Graff JT; Cramer JD
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):317-326. PubMed ID: 36821132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
    Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals.
    Liao CT; Lee LY; Lee SR; Ng SH; Liu TW; Chien CY; Lin JC; Wang CP; Terng SD; Hua CH; Chen TM; Chen WC; Tsai YT; Kang CJ; Tsai CY; Chu YH; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Yen TC; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Wen YW
    Front Oncol; 2022; 12():1019555. PubMed ID: 36452510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
    Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines.
    Lee LY; Lin CY; Cheng NM; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(19):6627-6641. PubMed ID: 34533269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database.
    Campbell DA; Pipkorn P; Divi V; Stadler M; Massey B; Campbell B; Richmon JD; Graboyes E; Puram S; Zenga J
    Am J Otolaryngol; 2021; 42(5):103012. PubMed ID: 33857781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
    Brinkman D; Callanan D; Jawad H; O'Sullivan R; O'Shea R; Dias A; Feeley L; Sheahan P
    Oral Oncol; 2022 Apr; 127():105797. PubMed ID: 35272227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.
    Stanford-Moore GB; Sola AM; Chan J; El-Sayed I; George J; Ha P; Ryan WR; Heaton CM
    Am J Otolaryngol; 2022; 43(2):103303. PubMed ID: 34894450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Risk Factors Associated With Unplanned Reoperation Following Vascularized Free Flaps Reconstruction of the Oral Squamous Cell Carcinoma.
    Fu G; Wang C; Zeng C; Liu Z; Han Z; Huang H; Cao M
    J Craniofac Surg; 2022 Nov-Dec 01; 33(8):2507-2512. PubMed ID: 36409870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum.
    Tsai CY; Lee SR; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Wen YW; Liao CT
    Oral Oncol; 2021 Jul; 118():105334. PubMed ID: 34020150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.